Sleep Architecture & Cognition in Focal Epilepsy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorUniversity of California, Davis

About this trial

Focal Epilepsy (FE) patients and healthy controls will wear an actigraph at home for one week and a home sleep study device at home for one night. Participants will then undergo two nights of testing (at least one week apart) at California Sleep Solutions (CSS) in Sacramento, CA. During the overnight stays, participants will have EEG leads placed and possibly a headband. They will undergo cognitive testing before they go to sleep and again in the morning. During one night of testing, sounds will be played in the room (acoustic stimulation). The sounds should not wake the participants.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18 - 40 years of age

Focal Epilepsy

Capacity to fully cooperate and follow directions

no other significant neurological disorders which could affect cognition

Disqualifiers

Current use of any medications that can significantly affect cognition

No severe sleep apnea

Trial design

Design model

Parallel

Treatments tested in this trial

  • Acoustic Stimulation (AS)

    Other intervention

    Acoustic Stimulation will be administered while participants have their sleep monitored.

  • SHAM Stimulation

    Other intervention

    No stimulation will be administered while participants have their sleep monitored.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Acoustic Stimulation (AS)Active comparator 1 intervention
Group B: SHAM StimulationSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Stanford Sleepiness Scale

Alertness Test; charts how alert a participant feels for up to 18 hours of the day for 7 days; scale is from 1-7 with higher scores meaning more sleepiness; abnormal is 4 and above

Time frame
participant completes over one week post EMU stay
2

Pittsburgh Sleep Quality Index (PSQI)

used to measure quality and patterns of sleep in adults

Time frame
screening
3

Epworth Sleepiness Scale

subjective measure of a patient's sleepiness; scores are from 0-24 with higher scores meaning more sleepiness; abnormal is 10 and above

Time frame
screening
4

Karolinska Sleepiness Scale / Sleep Diary

Self-administered indication of sleepiness; scores are from 1-9 with higher scores meaning more sleepiness; abnormal is 7 and above

Time frame
screening

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.